Joi+Blokes Review: Quarterly GLP-1 Prices, Separate Drug Bills and Unsettled Cancellation Terms

At Joi+Blokes, the smallest advertised monthly price is not necessarily the smallest treatment bill. Its $99-per-month Zepbound program excludes medication and is presented as a $297 three-month service. Its compounded semaglutide and tirzepatide programs include medication, but advertise discounted first months alongside quarterly billing. Those differences matter more to a household budget than comparing the headline numbers alone: one price buys professional support without the drug, while another bundles medication and services but leaves the exact opening transaction unstated.

This documentary review examines the official pages and terms consulted October 19, 2026. Joi+Blokes documents a genuine weight-management offering alongside hormone and wellness services, but describes itself contractually as a platform connecting patients with independent medical providers rather than directly practicing medicine. Its pages provide substantial detail about coaching, pharmacy arrangements and payment options. They also disagree about cancellation and refunds. The practical task is to separate what is priced clearly from what still needs a plan-specific written answer before payment.

At a glance

Compounded semaglutide: Subcutaneous compounded semaglutide is advertised at $179/month, with the first month $99, billed quarterly; medication, dosing support, clinician consultations and health coaching are included.
Sources: [5]
Compounded tirzepatide: Subcutaneous compounded tirzepatide is advertised at $249/month, with the first month $149, billed quarterly, with the same listed service inclusions.
Sources: [5]
Zepbound service versus medication: The service costs $99/month, presented as $297 for three months. Medication is excluded; the listed Lilly Direct vial purchases are cash-only and not eligible for insurance coverage.
Sources: [3]
Subscription commitment: General terms specify at least three consecutive months and cancellation thirty days before the next monthly processing date after that commitment, despite more flexible wording elsewhere.
Sources: [6] [5]
Platform responsibility: Joi+Blokes says it does not practice medicine or directly provide healthcare; it connects users with third-party medical providers.
Sources: [6]

Start with the transaction, not the monthly headline

The compounded semaglutide offer reads “$179/mo (first month $99) billed quarterly.” Compounded tirzepatide reads “$249/mo (first month $149) billed quarterly.” These are introductory monthly figures within a quarterly billing arrangement, not documented pay-as-you-go monthly options. The supplied pages do not state the exact initial quarterly charge. Rather than reconstructing a checkout total, request the amount collected today, the period it covers and the amount and date of the next automatic charge.

Both compounded offers expressly include medication, dosing support, clinician consultations and health coaching. That makes them different purchases from the Zepbound service, which excludes medication. However, quarterly billing does not by itself establish how many vials arrive, how much medication is dispensed or whether delivery occurs in one shipment. The materials do not settle those details. A useful quote should identify the formulation and shipment arrangement as well as the service period being purchased.

This is a case where the distinction explained in our first-payment guide has immediate practical value. An introductory month is a price condition, not proof that only that amount will be charged initially. Equally, the published ongoing monthly amounts should not disappear behind a vague statement that pricing is uncertain. Joi+Blokes supplies those figures; the missing piece is how they translate into the opening quarterly transaction and subsequent billing notices.

Published program prices are not interchangeable treatment totals
Program	Advertised charge	Key inclusion or boundary
Compounded semaglutide injection	$179/month; first month $99; billed quarterly	Medication, dosing support, clinician consultations and coaching included
Compounded tirzepatide injection	$249/month; first month $149; billed quarterly	Medication, dosing support, clinician consultations and coaching included
Compounded liraglutide injection	$299/month	Virtual visits, coaching, lab access and continuous support listed; lab charges not defined
Zepbound service	$99/month; $297 for a three-month service	Medication excluded and purchased separately

Sources: [5]

Zepbound creates a separate pharmacy budget

The Zepbound page is clearer about its service charge: $99 per month, presented as $297 for a three-month service. It lists virtual provider visits, personalized health coaching, laboratory access and continuous support, then explicitly says medication is not included. The named product is Zepbound, a tirzepatide injection. Its branded-product status should not be transferred to the compounded tirzepatide program simply because both pages name the same active ingredient.

The page separately lists Zepbound vial prices of $349/month for the 2.5 mg presentation, $499/month for 5 mg, $599/month for 7.5 mg and $699/month for 10 mg. These are presentation-specific prices, not dosing recommendations. After provider approval, patients receive a text from Lilly Direct to complete the medication purchase. The page says these vials are available only through cash payment, are not eligible for insurance coverage and have prices subject to change.

Joi+Blokes also advertises payment and receipt of Zepbound within 72 hours after approval and connection by text. That is a provider delivery claim, not a stated deadline for completing the clinical review. The service payment and pharmacy purchase remain distinct responsibilities. Before enrolling, establish when each is charged and what happens if the pharmacy transaction cannot be completed. Separate program and pharmacy bills deserve separate lines in a budget rather than being treated as one subscription.

Sources: [3]

Cancellation language could change the effective cost

The compounded program page advertises “No membership fees” and says users can adjust or cancel their plan anytime. The general terms, however, say subscription enrollment requires payment for a minimum of three consecutive months, with automatic charges according to the product or service. They allow cancellation thirty days before the next monthly processing date after the initial commitment concludes. The supplied documentation does not reconcile those provisions with the compounded plans’ quarterly billing.

Refund wording is similarly consequential. A prescription-product statement says a licensed provider must determine whether a prescription is appropriate and promises an immediate refund if it is not. In contrast, the insurance-backed GLP-1 subscription policy says paid subscription fees cannot be refunded even if the person is not a candidate or does not obtain approval. These statements may concern different purchases, but the evidence does not establish precisely which rule applies to every enrollment pathway.

The practical question is not simply whether cancellation is possible. It is which charges remain owed, when cancellation takes effect and whether any previously paid amount is refundable. Prescription-product sales are final and returns are not accepted; diagnostic laboratory and laboratory-subscription sales are also nonrefundable. Obtain the applicable policy in writing, including the notice deadline and next charge. Our cancellation and refund guide explains why stopping renewal and recovering money are separate questions.

Sources: [5] [6] [8]

Laboratory access is not a defined laboratory allowance

Laboratory language is another place where a seemingly comprehensive price needs clarification. The compounded program page says labs are not required but are available. The Zepbound FAQ likewise says they are not required and names three optional panels: Complete Hormone Panel, Advanced Panel and Comprehensive Panel. A shared module asks how users would like to get tested, but does not establish a treatment-specific testing requirement.

The compounded liraglutide program costs $299 per month and lists virtual provider visits, personalized coaching, laboratory access and continuous support. It describes liraglutide as a compounded formulation administered by subcutaneous injection. The phrase “lab access” does not establish that panel costs, blood collection or repeat testing are included. The same uncertainty affects the Zepbound service description. Ask which tests are required for the actual prescribed program and obtain their charges separately from the advertised service amount.

Joi+Blokes also advertises 65% off diagnostic labs for new customers using LABS65; the supplied banner gives no expiration date. It says diagnostic pricing differs in New York and New Jersey because of local requirements. Those details make a personalized laboratory quote more useful than a broad discount claim. Since laboratory purchases and subscriptions are described as final and nonrefundable, confirming testing and collection charges for the selected program matters before ordering tests, not after a purchase has been made.

Sources: [7] [3] [5] [4] [8]

What the bundled support actually promises

The compounded plans advertise unlimited health-coach visits, clinician access and support, unlimited messaging, nutrition and lifestyle support, home delivery and a community. These are meaningful service descriptions when comparing what a recurring fee purchases. They do not, however, establish unlimited prescribing visits or immediate clinician availability. The general terms specifically warn that communication with providers may not occur in real time. The evidence supplies neither a response-time commitment nor a defined follow-up appointment schedule.

The distinction between coaching and medical care is explicit. Joi+Blokes says health coaches are not doctors and cannot prescribe, diagnose medical conditions or provide specific medical advice. Its website identifies Melissa Loseke, DO, as medical director and Lauren Dulay, NP, as director of clinical operations and lead clinician. Those are company-stated roles, not independent credential verification. A nurse practitioner is not a physician, and a named leadership team does not identify the professional who will handle an individual prescription.

Enrollment begins with a health-history form and a clinician discussion or review. Prescription consultations may be synchronous or asynchronous, and informed consent is required for telemedicine. A provider can decide that an issue requires an in-person visit or services unavailable through the platform, ending platform treatment for that particular issue. For budgeting, ask how that decision affects an already purchased program and whether outside care would be an additional expense; the supplied materials do not answer every such scenario.

Sources: [4] [5] [6]

The pharmacy and location determine important boundaries

Joi+Blokes says it treats patients and ships medications only within the United States. That does not confirm availability in every state, and its compounded semaglutide page explicitly says that medication is unavailable in some states. The terms restrict services to people who have reached the age of majority in their jurisdiction. The supplied evidence does not provide a complete medication-by-state availability list or detailed provider-specific clinical eligibility criteria, so location should be confirmed before relying on an advertised price.

The terms list Strive Pharmacy, Pharmacy Hub, Tailor Made Compounding Pharmacy, Cadre Labs LLC, Empower Pharmacy, LillyDirect Self Pay Pharmacy Solutions doing business as GiftHealth, and Partell Pharmacy as partners dispensing prescriptions. A partner list does not identify which pharmacy will fulfill a particular order or establish that each named entity compounds it. If another pharmacy is selected, the terms say the prescription can be sent there, but the patient must obtain the medication and pay that pharmacy directly.

The terms also warn that prescriptions may arrive without child-resistant packaging. General preparation and delivery timelines for the compounded products and liraglutide, refrigeration arrangements and replacement policies for lost or damaged orders are not established in the supplied materials. FDA advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy. That makes the identity and contact route of the actual dispenser a practical part of the purchase, not merely an administrative detail.

Sources: [6] [4] [5] [1]

Insurance assistance and account payments are different benefits

Joi+Blokes says it assists with prior authorizations and prescription submissions but does not bill insurers directly. Its broader FAQ mentions possible coverage for Ozempic, Wegovy, Zepbound and Mounjaro without guaranteeing it. That general statement cannot override the specific Zepbound vial pathway described as cash-only and ineligible for insurance coverage. Readers should distinguish help obtaining a coverage decision from an insurer actually paying a service or pharmacy claim.

The compounded page describes HSA/FSA payment through Flex for eligible amounts after verification and, when required, approval of a letter. A remaining balance can be paid using a secondary method. This is a conditional payment arrangement, not proof that every purchase qualifies or that an account has sufficient funds. The useful confirmation is the amount Flex approves for the particular transaction and the balance due through another payment method, rather than a general assumption based on account ownership.

For insured alternatives, ask the plan about the exact prescribed product and pharmacy channel before treating coverage as part of the budget. NIDDK notes that coverage varies between plans, separately from insurance acceptance for a consultation. Our insurance and self-pay guide develops that distinction. For Joi+Blokes specifically, obtain separate written answers about the service fee, any authorization assistance and the medication purchase; one favorable answer does not resolve the other two.

Sources: [4] [3] [5] [2]

Price comparisons need product-specific evidence

Joi+Blokes acknowledges that its compounded GLP-1 preparations are not FDA approved and have not been formally evaluated by FDA for safety, quality or effectiveness. Its semaglutide page says concentration and added ingredients, such as B12, glycine or L-carnitine, depend on individual clinical needs. That leaves formulation details to be confirmed for the actual prescription. Neither a lower price nor a bundled coaching program establishes the clinical performance of that particular preparation.

FDA recommends compounded drugs when an individual's medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence, but neither does naming semaglutide or tirzepatide establish equivalence to an approved product. FDA has also received reports of compounded-medication measurement and administration errors, some involving hospitalization. Instructions should therefore come from the prescriber or pharmacist, not from calculations based on a review or a price comparison.

For a final cost check, request a single written summary naming the medicine, formulation, dispensing pharmacy, first charge, renewal charge, included services, laboratory obligations and cancellation rules. Ask for the appropriate contact path for clinical questions, billing disputes and shipment problems. The available documents establish substantial offerings, but not a response-time standard, complete state coverage, language assistance or a universal delivery policy. Those gaps do not prove poor service; they identify what the published price cannot settle.

Sources: [5] [6] [1]

Questions & answers

Can I pay only $99 to try compounded semaglutide for one month?

The page advertises a $99 first month, but also says the $179/month program is billed quarterly. It does not document a standalone $99 one-month purchase or the exact opening quarterly charge. General subscription terms also specify a three-month minimum. Ask for the checkout total and applicable commitment before assuming the introductory price creates a one-month trial.

Sources: [5] [6]

Does the $297 Zepbound service include any medication?

No. The page expressly excludes medication from the $297 three-month service. It separately lists monthly vial prices by presentation and routes the purchase through Lilly Direct after provider approval. Those particular vials are described as cash-only and not eligible for insurance coverage. Confirm the current pharmacy price because the page says prices can change.

Sources: [3]

Are blood tests mandatory before Joi+Blokes treatment?

The compounded and Zepbound pages say labs are not required. A shared module asks how users would like to get tested, but does not establish a treatment-specific testing requirement. “Lab access” does not define which testing or collection charges are included; confirm these for the selected program and request an itemized quote.

Sources: [5] [3] [7]

Will I get my payment back if no prescription is approved?

Do not assume one refund rule covers every pathway. A prescription-product statement promises an immediate refund if prescribing is inappropriate, but the insurance-backed GLP-1 policy says subscription fees already paid are nonrefundable even without candidacy or approval. Obtain the rule for your exact purchase in writing. An immediate-refund statement also does not establish when funds will appear in a bank account.

Sources: [5] [8]

Can I use a pharmacy outside Joi+Blokes' partner network?

The general terms describe sending a prescription to a selected outside pharmacy, with the patient responsible for obtaining and paying for the product directly. They do not establish how that choice changes a medication-inclusive program's fee. Ask about any price adjustment first. The published Zepbound vial prices specifically concern the Lilly Direct purchase pathway, not every possible pharmacy.

Sources: [6] [3]

Does unlimited messaging mean immediate medical help?

No immediate-response standard is documented. The compounded page advertises unlimited messaging and clinician support, but the terms say provider communications may not be real time. Unlimited health-coach visits are also distinct from prescribing care: coaches cannot diagnose, prescribe or provide specific medical advice. Ask who receives messages, how clinical concerns are escalated and what response window the program actually offers.

Sources: [5] [6]

Our assessment

Joi+Blokes publishes more useful pricing detail than a simple consultation-only listing: it distinguishes medication-inclusive compounded programs from a separate-fee Zepbound service and identifies coaching, pharmacy and payment arrangements. Its principal budgeting weakness is not a complete absence of prices, but unresolved boundaries around those prices. The exact introductory quarterly charge, laboratory expenses and applicable cancellation and refund provisions need written clarification. The program may be worth further consideration for someone seeking the documented combination of virtual care and support, but the evidence does not justify treating the headline monthly amount as a complete, easily reversible purchase. A sensible next step is a plan-specific quote with the next renewal date, medication channel and controlling exit terms attached—not an assumption that the most favorable wording applies everywhere.

Visit Joi+Blokes’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Joi+Blokes Review: Quarterly GLP-1 Prices, Separate Drug Bills and Unsettled Cancellation Terms

At a glance

01Start with the transaction, not the monthly headline

02Zepbound creates a separate pharmacy budget

03Cancellation language could change the effective cost

04Laboratory access is not a defined laboratory allowance

05What the bundled support actually promises

06The pharmacy and location determine important boundaries

07Insurance assistance and account payments are different benefits

08Price comparisons need product-specific evidence